Startup Valuation Methods Explained: How to Value Your Startup

Whether you are a founder preparing to raise capital, an angel investor evaluating deals, or simply curious about how startups get their price tags — understanding valuation methods is essential. The challenge? Early-stage companies rarely have the revenue, profits, or history that traditional valuation relies on.

This guide explains six proven startup valuation methods, from the qualitative Berkus Method for pre-revenue companies to the quantitative DCF for later-stage startups. We cover pre-money vs. post-money valuation, how dilution works, and include worked examples for each method.

Valuation methods at a glance

Different methods suit different stages. Here is a quick comparison to help you choose the right approach:

Pre-money vs. post-money valuation

Before diving into specific methods, you need to understand the two most fundamental terms in startup fundraising: pre-money and post-money valuation.

Pre-money valuation is what your company is worth before the new investment goes in. Post-money valuation is what it is worth after. The investor's ownership percentage is calculated from the post-money figure.

Always clarify whether a quoted valuation is pre-money or post-money. A "$5M valuation" could mean a $5M pre-money (investor gets a smaller slice) or a $5M post-money (investor gets a larger slice). This distinction can shift ownership by 10%+ in early rounds.

Method 1: The Berkus Method

The Berkus Method, developed by angel investor Dave Berkus, is one of the simplest and most widely used frameworks for pre-revenue startups. Instead of relying on financial projections (which are notoriously unreliable at the early stage), it assigns value based on progress across five risk-reducing factors.

Berkus worked example

A health-tech startup with a working MVP, experienced founders (one exit), a hospital partnership, but no revenue yet:

Method 2: Revenue Multiples

Once a startup has revenue, the simplest valuation approach is to multiply annual revenue (or ARR for SaaS) by a sector-specific multiple. This method is intuitive and widely used, but the "right" multiple varies enormously by industry, growth rate, and market conditions.

Revenue multiples worked example

A B2B SaaS startup doing $500K ARR with 150% net revenue retention and 3x year-over-year growth:

Method 3: Discounted Cash Flow (DCF)

DCF is the gold standard of corporate valuation, but it is tricky for startups. It estimates the present value of all future cash flows the company will generate, discounted back at a rate that reflects the risk of those cash flows actually materialising.

Why DCF is hard for startups: Cash flows are speculative — most startups are burning cash and projecting revenue that may never materialise. Discount rates are extremely high (typically 30%–60% for early-stage, vs. 8%–12% for public companies). And 80%–90% of a startup's DCF value often comes from the terminal (exit) value, which is itself highly uncertain.

DCF works best for Series B+ companies with at least 2–3 years of revenue history and somewhat predictable growth. For pre-revenue or early-revenue startups, use the Berkus, Scorecard, or VC Method instead.

Method 4: Comparable Transactions

This method values your startup based on what similar companies were valued at in recent funding rounds or acquisitions. It is the "what did the market pay?" approach.

Where to find comparables: Crunchbase and PitchBook for recent rounds in your sector and stage. AngelList and Carta for benchmark data from thousands of startup rounds. Industry reports for sector-specific valuation data. Local accelerators and investor networks for regional benchmarks.

Key matching criteria: For comparables to be meaningful, match on industry/vertical, funding stage, revenue range and growth rate, geographic market, business model (SaaS, marketplace, D2C), and recency (ideally within the last 12–18 months). Poor comparables are worse than no comparables — comparing your seed-stage startup to a unicorn will not help your credibility with investors.

Method 5: The VC Method

The Venture Capital Method works backward from a projected exit to determine what the company should be worth today. It is the method VCs actually use to calculate whether a deal can deliver their target return.

VC Method worked example

What is "Target ROI"? VCs typically target 10x–30x return on early-stage investments because most portfolio companies will fail. A 20x target does not mean greed — it means the VC needs the winners to cover the losers. The higher the risk (earlier stage), the higher the required multiple.

Method 6: The Scorecard Method

The Scorecard Method (also called the Bill Payne Method) combines the simplicity of the Berkus approach with market-based benchmarking. It starts with the average valuation for comparable startups, then adjusts up or down based on weighted qualitative factors.

If the average seed valuation in your market is $4M:

Understanding dilution

Dilution is one of the most misunderstood concepts in startup fundraising. Every time a startup issues new shares to investors, existing shareholders' percentage ownership decreases. This is normal and expected — but understanding the math is crucial.

Typical valuations by stage (2026)

These ranges reflect primarily US and Western European markets. Valuations in Southeast Asia, Latin America, or Africa tend to be 30%–50% lower at the same stage for comparable companies. Local investors benchmark to local comparables, not Silicon Valley norms.

Common valuation mistakes to avoid

Comparing to unicorns. Just because a competitor raised at $100M does not mean your seed-stage company is worth $10M. Investors use stage-appropriate comparables, not aspirational ones.

Overestimating market size. Saying "we are targeting a $50B market" means nothing without a credible path to capturing a meaningful slice. Investors care about your serviceable addressable market (SAM), not the total addressable market (TAM).

Relying solely on financial projections. Founders' five-year projections are almost always wrong. Experienced investors know this, which is why qualitative methods like Berkus and Scorecard exist. Use projections as a guide, not gospel.

Ignoring dilution over multiple rounds. Many first-time founders optimise for a high valuation in one round without modelling how 3–4 rounds of fundraising will affect their ownership. A slightly lower seed valuation with a smaller raise can leave you with more equity at exit.

Using only one method. No single valuation method is definitive. Triangulate with 2–3 approaches to build confidence in your range and defend it to investors.